Literature DB >> 26141124

Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System.

Eduardo R Zimmer1, Antoine Leuzy2, Diogo O Souza1, Luis V Portela3.   

Abstract

In a recent review published in Molecular Neurobiology, Kamat and colleagues (Mol Neurobiol. 2014 Dec;50(3):852-65) highlighted the cellular and molecular mechanisms involved in Okadaic acid (OKA)-induced neurotoxicity. In this review, the authors underline a wide range of pathological signaling pathways involved in OKA-induced neurotoxicity; however, the role of glutamate was only briefly described. We believe that the hyperactivation of the glutamatergic system is a key pathophysiological player in OKA-induced neurotoxicity and deserves serious attention. In this commentary, we propose an integrative model linking glutamate and PP2A and put forward some unanswered questions.

Entities:  

Keywords:  Excitotoxicity; Glutamate; Okadaic acid; Protein phosphatase 2A; Tau hyperphosphorylation

Mesh:

Substances:

Year:  2015        PMID: 26141124     DOI: 10.1007/s12035-015-9321-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  14 in total

1.  Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.

Authors:  C X Gong; T Lidsky; J Wegiel; L Zuck; I Grundke-Iqbal; K Iqbal
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

Review 2.  Tau pathology in Alzheimer disease and other tauopathies.

Authors:  Khalid Iqbal; Alejandra del C Alonso; She Chen; M Omar Chohan; Ezzat El-Akkad; Cheng-Xin Gong; Sabiha Khatoon; Bin Li; Fei Liu; Abdur Rahman; Hitoshi Tanimukai; Inge Grundke-Iqbal
Journal:  Biochim Biophys Acta       Date:  2005-01-03

3.  An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues.

Authors:  P Cohen; S Klumpp; D L Schelling
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

Review 4.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

Review 5.  Memantine: a review of its use in Alzheimer's disease.

Authors:  Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.

Authors:  Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Eur J Neurosci       Date:  2005-10       Impact factor: 3.386

7.  Phosphoprotein phosphatase activities in Alzheimer disease brain.

Authors:  C X Gong; T J Singh; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

8.  Activity-dependent p25 generation regulates synaptic plasticity and Aβ-induced cognitive impairment.

Authors:  Jinsoo Seo; Paola Giusti-Rodríguez; Ying Zhou; Andrii Rudenko; Sukhee Cho; Kristie T Ota; Christine Park; Holger Patzke; Ram Madabhushi; Ling Pan; Alison E Mungenast; Ji-Song Guan; Ivana Delalle; Li-Huei Tsai
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

Review 9.  Protein phosphatase 2A dysfunction in Alzheimer's disease.

Authors:  Jean-Marie Sontag; Estelle Sontag
Journal:  Front Mol Neurosci       Date:  2014-03-11       Impact factor: 5.639

10.  In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.

Authors:  Eduardo Rigon Zimmer; Antoine Leuzy; Venkat Bhat; Serge Gauthier; Pedro Rosa-Neto
Journal:  Transl Neurodegener       Date:  2014-03-15       Impact factor: 8.014

View more
  3 in total

1.  Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation.

Authors:  Yang Yang; Xingxing Jia; Jianchao Feng; Zhiyong Wang; Yu Cao; Jiangang Liu; Hao Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-20       Impact factor: 2.629

2.  Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.

Authors:  Hengjing Cui; Tommi Kilpeläinen; Lydia Zouzoula; Samuli Auno; Kalevi Trontti; Sampo Kurvonen; Susanna Norrbacka; Iiris Hovatta; Poul Henning Jensen; Timo T Myöhänen
Journal:  J Cell Mol Med       Date:  2021-09-05       Impact factor: 5.310

3.  Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.

Authors:  Cuicui Yang; Xuelian Li; Wenbin Gao; Qi Wang; Li Zhang; Yali Li; Lin Li; Lan Zhang
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.